Peak Pharma

This book argues that we have reached the ‘peak’ of a particular model for pharmaceutical innovation—the neoliberal value model that has been in place since the early 1980s. ‘Peak’ designates a state where a given and socially significant resource becomes rarer, more difficult to access, and more ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Geiger, Susi, Bourgeron, Théo
Format: Online
Language:English
Published: Oxford University Press 2026
Subjects:
Online Access:https://library.oapen.org/handle/20.500.12657/111768
Tags: Add Tag
No Tags, Be the first to tag this record!